|
Medtech Snapshot episode #121 features Bill Carpou, CEO of Octane OC, an Orange County, CA based technology accelerator with a specialty in lifescience startups. Listen in as Bill walks us through the advantage accelerator's like Octane offer, how startups can gain access to their first rounds of 'smart money' and the importance of startup coachability. Read the Full Interview
Welcome back to another MidTech Snapshot. With us today is Bill Karpu from Octane, and I'm really excited to talk through a variety of topics today, everything from Raising Capital to their Launchpad program, and even a brand new AI hub that's in development here in Orange County. So stay tuned. Alright, Bill, so I'm really excited to start our discussion off today looking at Raising Capital. You know, I mean, this has been a huge discussion for MidTech startups, obviously, in particular, but, you know, it's, it's not been the easiest as of recent in your organization over the years. You know, since 2010, if I recall, you all have done 1600, give or take raises, and 86% of the companies that go through your accelerator, they've been getting funding in about 15 months. Walk us through, how is that possible first? I mean, those are some pretty good stats. And what's the difference between the companies that are getting funding through your program versus the one that aren't? Yes, Travis, I mean, they are good statistics, if you look at it from that standpoint. And one of the reasons is that, you know, we work with or see about 550 companies a year, and whittle that down or do the diligence to get it to about 65 that we work with. So we're already diligently out, if I could use that phrase, about 88% of the companies that we see. So, you know, we're dealing with a smaller and tighter nucleus. So, you know, that's that's one component. The second and third are really, really critically fundamental to what Octane does. So, you know, one is that we've got a high degree of credibility with investors right now. And, you know, we're positioning these companies in, you know, I call it their first real smart money. So it's either family offices, you know, ultra high net worth individuals or venture, you know, either strategic or institutional. So we've got we've got relative credibility with each of them. On the other is that we we've produced really good results and we've got data that backs up and an AI tool called Haystacks that we could give an investor a probability of success of their investment.
0 Comments
|
AboutThe MedTech Snapshot Podcast, hosted by Square-1 Engineering’s Travis Smith, features quick insights from industry executives on topics like startups, funding, product development, finance, manufacturing, and more. Archives
October 2025
September 2025
August 2025
July 2025
June 2025
May 2025
April 2025
March 2025
February 2025
January 2025
Categories
All
2023
2024
2025
21 CFR 820
Accelerator
Acquisition
AdvaMed
Agile
Artificial Intelligence
Breakthrough Moment
Career
Clinical
Clinical Trials
Compliance
Contract Manufacturing
CRO
Cyber Security
Embedded Systems
Entrepreneur
FDA
Finance
FMEA
Funding
Global Operations
Government
Healthcare
Hiring
History
Incubator
Industrial Design
International
Investor
ISO
ISO 13485
Jp Morgan
KPI
Leadership
M&A
Machine Learning
Management
Manufacturing
Medical Device
Medtech
Medtech Snapshot
Networking
Operations
Orange County
OUS
Outsourcing
Patient Advocacy
Podcast
Policy
Private Equity
Product Design
Product Development
Production
Professional Development
Project Management
Quality Assurance
Quality Systems
RAQA
Regulation
Risk
Risk Management
Root Cause Analysis
Sales
Scope Creep
Snapshot
Software
Southern California
Startup
Start Ups
Strategy
Supply Chain
Talent
Technology
Tech Transfer
Term Sheets
Top Grading
Trends
User Experience
User Needs
Venture Capital
Voice Of The Customer
|
RSS Feed